Advisor Group Holdings, Inc. Bio Xcel Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 8,500 shares of BTAI stock, worth $20,230. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,500
Previous 8,500
-0.0%
Holding current value
$20,230
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding BTAI
# of Institutions
48Shares Held
3.02MCall Options Held
22.2KPut Options Held
40.2K-
Ubs Group Ag1.28MShares$3.04 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$2.83 Million0.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$1.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$742,4760.0% of portfolio
-
Wells Fargo & Company San Francisco, CA199KShares$473,6430.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $66.7M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...